Populations underrepresented in clinical trials face worse health outcomes that will cost the U.S. trillions of dollars over the next three decades, according to a new report form the National Academies of Science, Engineering and Medicine.
Other featured articles
The Relationship Between Multimorbidity and Types of Chronic Diseases and Self-Rated Memory
This study explores the impact of multimorbidity and types of chronic diseases on self-rated memory in older adults in the United States.
Value of Reducing Wait Times for Chimeric Antigen Receptor T-Cell Treatment: Evidence From Randomized Controlled Trial Data on Tisagenlecleucel for Diffuse Large B-Cell Lymphoma
Researchers aimed to quantify the value of reducing chimeric antigen receptor T-cell (CAR-T) treatment wait times on patients with refractory and relapsed aggressive blood cancer who can newly gain access to treatment or access treatment earlier in their disease course.
Improving Care of People with Serious Medical Illness: An Economic Research Agenda for Palliative Care
In 2020, Schaeffer Center established an Advisory Panel on Palliative Care. In this post, the panel outlines next steps to increase the quality of care of frail people with multiple chronic conditions.
About this section
Chronic diseases are among the most preventable and costliest conditions, consuming the overwhelming majority of Medicare resources. The Schaeffer Center assembles leading minds from across disciplines to address this challenge, striving to simplify labyrinthine systems of care and promote healthier outcomes.